Search Results
Results found for "Glaxo Inc"
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
By increasing sensitivity, so-called “silent” antagonists reveal themselves as weak agonists.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
discovery teams can accelerate identification, characterization, and lead optimization—reducing noise while increasing GPCR Premium Membership Gives You an Edge Premium provides weekly curated intelligence, including expert FAQ: Premium Membership 🔹 What’s included?
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
Terbium, a second-generation donor, is brighter than Europium (10-20 times), which increases sensitivity The ratiometric readouts correct many inconsistencies such as pipetting errors. They can be combined with second generation acceptors like d2, as well as brighter donors, further increasing
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
This includes diseases such as depression, Parkinson’s, schizophrenia, and Alzheimer’s.
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Design smarter inotropes: Dobutamine’s α-activity harnesses baroreflexes to increase contractility without Offered in four flexible formats that meet scientists where they are—Anti-FLAG, Anti-IgG, and SNAP-tag included FAQ: Premium Membership 🔹 What’s included?
- Why Opposing Processes Matter for Your Next GPCR Drug
pressure in healthy volunteers might not drop blood pressure at all in heart failure patients, because increased
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
GPCR Podcast , where he shares the story behind pHSense , including its application in real-time internalization
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Upcoming events: Preview of Discovery on Target 2025 (Boston, Sept 24‑25), including GPCR‑Track breakout FAQ: Premium Membership 🔹 What’s included?
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
FAQ: Premium Membership 🔹 What’s included?
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
this transition by offering optimized fluorescent ligands specifically designed for GPCR targets , including
- From Snapshots to Predictions: Why Mechanism of Action Matters
Instead of saying, “This looks like partial agonism” , you can ask: What happens if concentration increases When Binding Increases Instead of Decreases Another trap: paradoxical results. Instead, binding increases. Without a framework, this looks like an assay error.
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
how a GPCR will respond to a given ligand — and what downstream effects it will trigger — remained incredibly The company’s goal is to model receptor dynamics — including biased signaling — to predict drug behavior He also underscores the value of developing cross-functional skills — including communication, strategy
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
FAQ: Premium Membership 🔹 What’s included?
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Figure 2.Left panel, confocal microscopy of living cells incubated for 1h at 37ºC with CELT-327. Right panel, the fluorescent signal is displaced when, after incubating with CELT-327, cells are incubated
- GPCR Happy Hour – Boston, Sept 2025
Their areas of focus include structural biology, protein production from Proteos, and nanoparticle characterization Axxam’s capabilities span the full spectrum of GPCR families, including aminergic, peptide, lipid, and Leveraging decades of experience, their services include AI-driven target identification, target validation Axxam also integrates breakthrough tools throughout the discovery process, including its pioneering organellar
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
“They’ve seen a 30 to 60 percent increase in the number of fentanyl samples that contain xylazine in Her next steps include using floxed mouse models and viral tools to dissect the downstream pathways
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
between Eli Lilly and Novo Upcoming events: September GPCR symposia across Europe, UK, and online—including FAQ: Premium Membership 🔹 What’s included?
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Must-read publications: Stay updated on cutting-edge research, including the potentiation of GPCR signaling Threat Avoided: Prevent costly late-stage failures by incorporating kinetic modeling early in your pipeline FAQ: Premium Membership 🔹 What’s included?
- Fluorescence Polarization in GPCR Research
readers are usually available in regular laboratories, although not all have FP filters, they are usually included Reference compounds XAC, ISVY-130, and MRS 1220 were included as standard A₃AR antagonists. 2.
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
Yet fentanyl is increasingly not alone.
- Why “Displacement” Misleads You: Allosteric Binding Demystified
When a PAM increases radioligand binding but suppresses functional response, it’s not broken pharmacology—it
- Advantages of Fluorescent Probes in GPCR Assays
limitations, especially safety concerns, low temporal resolution and the need for specialized facilities including Our portfolio also includes all kinds of dyes, such as pharmacophores conjugated to near-infrared fluorophores Once the cells are ready, the fluorescent ligand is added, and the cells are incubated with it for a After incubation, cells are observed using a confocal microscope. Celtarys’ protocol section includes detailed protocols for diverse applications and fluorescent ligands
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Wendy Young’s talk, during session 3 on day 2, was also incredible.
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
Cannabinoids have the potential to treat a variety of diseases, including neurological and metabolic The curves were obtained using 100nM of probe and increasing concentrations of Δ9-THC, Δ9-THCA and Δ9
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
when talking about SCRAs (Synthetic Cannabinoid Agonists), as one of the series developed by Pfizer, including Tag-Lite® competition binding curves were obtained by using 100 nM of CELT-335 and increasing concentrations Competition binding curves were obtained through Tag-lite® technology using 10 nM of CELT-335 and increasing For further validation, a larger range of compounds will be tested, including screening chemical libraries
- Radioligands vs. Fluorescent Ligands: Binding Assays
While their high specificity and extensive experience working with them, other drawbacks include radiation
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
temporary therapeutic effects.[3,4] Since dopaminergic signaling is very complex, there’s a need to increase FA of 3 nM (orange squares) or 0.5 nM (blue circles) CELT-419 were measured after 2 h incubation with Change in FA level was measured after incubation of 0.5 nM CELT-419, 1 μL BBV/well (CD3R = 0.7 nM), and HEK293-D3R cells in DMEM medium with added 9% FBS and antibiotic antimycotic solution were incubated As the next step, the cells were incubated with different concentrations of CELT-419 to determine its
- Conjugation Strategies for Probe Development
It’s reversible under non-reducing conditions. [ 4] Other strategies include click chemistry, more There’s no need for any catalysts; all reagents will be incorporated in the structure of the final compound
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Learn to tie your program's progress directly to your funding runway, incorporating crucial early commercial
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Career opportunities: A curated list of new positions, including a Research Associate, a Senior Research misinterpreting your data by understanding how slow-offset kinetics can mimic classical patterns, leading to incorrect FAQ 🔹 What’s included?






























